Δ133p53α enhances metabolic and cellular fitness of TCR-engineered T cells and promotes superior antitumor immunity

BACKGROUND: Tumor microenvironment-associated T cell senescence is a key limiting factor for durable effective cancer immunotherapy. A few studies have demonstrated the critical role of the tumor suppressor TP53-derived p53 isoforms in cellular senescence process of non-immune cells. However, their...

Descripción completa

Detalles Bibliográficos
Autores principales: Legscha, Kevin Jan, Antunes Ferreira, Edite, Chamoun, Antonios, Lang, Alexander, Awwad, Mohamed Hemaid Sayed, Ton, Gigi Nu Hoang Quy, Galetzka, Danuta, Guezguez, Borhane, Hundemer, Michael, Bourdon, Jean-Christophe, Munder, Markus, Theobald, Matthias, Echchannaoui, Hakim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Immune Cell Therapies and Immune Cell Engineering
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194333/
https://www.ncbi.nlm.nih.gov/pubmed/34112738
http://dx.doi.org/10.1136/jitc-2020-001846

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8194333/
https://www.ncbi.nlm.nih.gov/pubmed/34112738
http://dx.doi.org/10.1136/jitc-2020-001846

Ejemplares similares